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Abstract
Background
In most emergency departments (EDs), few patients account for a relatively high number of
ED visits. To improve the management of these patients, the university hospital of Lau-
sanne, Switzerland, implemented an interdisciplinary case management (CM) intervention.
This study examined whether the CM intervention—compared with standard care (SC) in
the ED—reduced costs generated by frequent ED users, not only from the hospital perspec-
tive, but also from the third-party payer perspective, that is, from a broader perspective that
takes into account the costs of health care services used outside the hospital offering the
intervention.
Methods
In this randomized controlled trial, 250 frequent ED users (>5 visits during the previous 12
months) were allocated to either the CM or the SC group and followed up for 12 months.
Cost data were obtained from the hospital’s analytical accounting system for the entire sam-
ple and from health insurance companies for a subgroup (n = 140). Descriptive statistics
and multivariate regressions were used to make comparisons between groups and assess
the contribution of patient characteristics to the main cost components.
Results
At the end of the 12-month follow-up, 115 patients were in the CM group and 115 in the SC
group (20 had died). Despite differences in economic costs between patients in the CM
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intervention and the SC groups, our results do not show any statistically significant reduction
in costs associated with the intervention, either for the hospital that housed the intervention
or for the third-party payer. Frequent ED users were big users of health services provided by
both the hospital and community-based services, with 40% of costs generated outside the
hospital that housed the intervention. Higher age, Swiss citizenship, and having social diffi-
culty increased costs significantly.
Conclusions
As the role of the CM team is to guide patients through the entire care process, the interven-
tion location is not limited to the hospital but often extends into the community.
1. Introduction
In many communities, although most patients visit hospital emergency departments (EDs)
occasionally, a small number of patients generate a disproportionate proportion of total atten-
dances. Depending on the definition, frequent users represent between 1 and 10% of the
patients seen in the ED and may account for up to 20–25% of annual visits [1, 2]. In Switzer-
land, frequent ED users accounted for 4.4% of all ED patients and represented 12.1% of all ED
visits at the Lausanne University Hospital in 2008–2009 [3].
Implications of this intensive use of hospital EDs have become a priority for clinicians, hos-
pital administrators, and policy makers. ED overcrowding may put pressure on medical staff
and budgetary resources, increasing waiting times and negatively affecting quality of care and
patient outcomes. A substantial share of ED visits are related to nonemergent conditions, or
issues that could be prevented or more appropriately managed in primary care or community
settings. This inefficient use of costly emergency care reduces the system-wide capacity to han-
dle “real” emergencies, hinders the intake and management of the entire pool of patients, and
contributes to the increase in overall health care expenditures.
Several interventions have aimed at managing frequent ED users more efficiently. Case
management (CM) is the most common type of such an intervention and has been imple-
mented in many countries for frequent ED users [4, 5], as well as for other groups with specific
diseases [6–12]. CM intervention consists of an interdisciplinary approach that assesses, plans,
personalizes, and guides the use of individual health service resources, at the same time coordi-
nating them, to improve patient outcomes and reduce use of health resources and their associ-
ated costs.
Several studies that targeted ED frequent users, including randomized controlled trials
(RCTs) and nonrandom comparative cohort designs, showed that CM interventions were asso-
ciated with improvement in patient satisfaction or quality of life [13, 14], as well as a reduction
in the mean or median number of ED visits [13, 15–19]. Other recent studies showed that CM
intervention appeared to be effective in reducing ED visits, but without reaching statistical sig-
nificance [20, 21]. In addition, CM interventions had an impact on costs, although the studies
used heterogeneous methods regarding cost outcomes and cost calculations. Considering the
perspective of the third-party payer (i.e., the insurer), studies reported reductions in ED charges
[15, 22], inpatient charges [16, 22], and combined ED and inpatient charges [23] following the
implementation of the intervention. Similarly, but from a hospital perspective, Shumway et al.
[13] reported that a group that received the CM intervention had lower ED costs and Murphy
and Neven [17] reported that such a group had lower total treatment costs.
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In these CM intervention cost analyses for ED frequent users, whatever the perspective
adopted, the outcomes of interest included only the costs of services provided in the ED or
within the hospital where the intervention was conducted. The investigators did not examine
the costs generated by the use of services provided in other local hospitals or in independent
primary care practices. One of the main objectives of CM interventions, however, is to limit
the need for costly ED visits by preventing the exacerbation of existing conditions and reduc-
ing the incidence of severe acute events. This is done by reorienting patients toward commu-
nity-based services and thus increasing their access to more appropriate (and potentially less
costly) primary care. Although some of these services may be delivered through ambulatory
consultations at the hospital that implements the CM intervention, they may also be offered by
primary care practices in the community. The costs of all of these substitute services should be
taken into account when conducting cost analyses of CM interventions to assess their broader
impact.
Thus, using data from an RCT comparing a CM intervention with standard care (SC)
among frequent ED users of the Lausanne University Hospital, Switzerland, we examined the
potential of such an intervention to reduce the costs of health care services from two different
perspectives. First, a cost analysis was conducted from the perspective of the hospital that
housed the intervention by appraising different health services used within its facilities. Sec-
ond, a broader analysis was done by examining the costs of health services used, both within
and outside the hospital that offered the intervention, from a third-party payer perspective. To
our knowledge, this study is the first to use an RCT design to investigate the impact of CM on
health care costs with a larger scope than that of the hospital implementing the intervention.
2. Methods
2.1. Setting
In Switzerland, access to health care is ensured through a universal health coverage system.
Since 1996, the Health Insurance Law has imposed mandatory health insurance (MHI) on all
Swiss residents, who are required to buy individual health insurance from one of the 53 com-
peting private insurance companies on the market. The dynamics of the market, ruled by the
Health Insurance Law, relies on 4 main principles: (1) Health insurers cannot make profits on
contracts for MHI, (2) consumers have free choice of their insurer, (3) insurers cannot refuse
or select individuals for MHI because of preexisting conditions or risk factors and are com-
pelled to accept any applicant, and (4) MHI covers a standard benefits package regulated by
federal legislation and including a comprehensive range of outpatient and inpatient care and
services [24].
Health coverage is financed through uniform per capita premiums paid to insurance compa-
nies. Patients pay a deductible that they select from a range of CHF 300 to 2,500 and an annual
participation fee that includes a copayment for health services used (10%). Higher deductible
levels are associated with a reduction in premiums. The level of cost sharing (deductible, coin-
surance of 10% up to an annual ceiling) is defined by law and is identical across insurers. Subsi-
dies are given to people with low incomes, so that almost the entire population is covered by
MHI [24]. In addition, patients are able to enroll in supplementary and complementary health
insurance at an extra cost from the same or a different insurer on a voluntary basis.
The third-party payer system, applicable to almost all companies and for all types of health
care services (outpatient, inpatient, medications), implies that the price of health care services
used by patients is not paid by the user or the provider, but by the insurer. Medical invoices are
sent to health insurance companies and are calculated on a fee-for-service basis for ambulatory
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physicians and outpatient services provided by hospitals, and on a diagnosis-related group pay-
ment system for inpatient care.
Funding of the health care system is split between different government levels and different
social insurance schemes. Resources are collected through taxes and MHI premiums. MHI
companies are the most important purchasers and payers in the system, financing 36% of total
health expenditures in the country (in 2015). Out-of-pocket payments finance 28% of total
health expenditures and government spending finances 18% [25]. Complementary and supple-
mentary voluntary health insurance plays a small role, financing about 6% of total health expen-
ditures. The balance in the system is kept because an increase in health expenditures observed
in the previous year directly affects the premium amount paid by the enrollees the next year.
2.2. Data
We used data from an RCT comparing a CM intervention with SC among frequent ED users
of the Lausanne University Hospital, an urban public hospital serving (with other non-univer-
sity hospitals) a population of 770,000 located in the French-speaking part of Switzerland. It is
one of the 5 teaching university hospitals in the country and provides primary care to the local
population, as well as tertiary and highly specialized care to a larger population area. In 2013, it
provided medical, surgical, and mental health care through 39,000 annual ED visits and 45,200
inpatient stays [26].
The trial recruited 250 adult frequent ED users (defined as 5 or more visits during the previ-
ous 12 months) who visited the ED between May 2012 and July 2013. The participants were
randomly and equally allocated either to the group receiving the CM intervention (n = 125) or
to the group receiving standard ED care (n = 125) and followed up over 12 months. The sample
size was determined for the first outcome, an expected comparative reduction of 2 ED visits per
year in the intervention group. The control group received SC through the ED, specialists, phy-
sicians, and nurses focusing on somatic and/or mental diseases and/or behavioral-specific acute
problems. The treatment group, in addition to SC, received CM intervention conducted by an
interdisciplinary team (4 nurses supervised by a general practitioner) whose role was to provide
social and medical support to each individual. During the baseline meeting, the social situation,
physical and mental health status, and risky behaviors of the patients were assessed by the team,
leading to the elaboration of a personalized care program. The monitoring of this program was
done during 3 other meetings with the team, at 1, 3, and 5 months later at the patients’ homes
or in an ambulatory setting or on the telephone. In addition, the patients could contact, at any
time, one of the members of the CM team. The primary goals of the CM team were to provide
practical assistance and appropriate referrals depending on the situation. Thus, if necessary,
social assistance in obtaining financial support, housing benefits in order to have stable housing,
or educational opportunities were offered. Patients were also referred to mental health services,
substance abuse management services, or a general practitioner or primary care provider, if
appropriate. The role of the CM team was to facilitate communication between social and
health care providers, both inside the hospital and in the community, in order to maintain con-
tinuity of care. More information on the trial is available from the published protocol [27].
The present study focused on costs of health care services used by patients and did not take
into account the costs of social assistance (social services) provided to frequent users. Costs of
health care services were assessed differently depending on the perspective adopted. For the
cost analysis from the hospital perspective, the true value of the resources that were needed to
provide health care services was used as a cost estimate. These data were obtained from the
hospital’s analytical accounting system, which assigns monetary values to resources involved
in providing health care to patients (costs of labor, pharmaceuticals and medical supplies,
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meals, linen and clothing, utilities, maintenance and repair of buildings and equipment, laun-
dry, cleaning, office supplies, communication, etc.). Costs were available over 12 months fol-
lowing enrollment in the trial. To allow for comparisons, we computed average monthly
hospital costs. Total hospital costs were split into 5 components, depending on the medical
nature of health care services used: ambulatory costs, somatic inpatient costs, rehabilitation
costs, psychiatric costs, and ED costs.
For the broader health care cost analysis, we used MHI claims data. These data were
obtained from each insurance company that was individually contacted for each participant
who had given his/her consent. The insurance companies that agreed to cooperate provided a
unique cost estimate corresponding to the global sum of individual costs over the inclusion
period of the study. Given the third-party payer system in Switzerland, these data represent a
unique estimate of total health costs from the third-party payer perspective, hereafter referred
to as total insurance costs. In addition, similar insurance cost data for health care services pro-
vided by Lausanne University Hospital were obtained from its invoicing department, which
centralizes all invoices before sending them to health insurance companies for reimbursement.
We then split total insurance costs into 2 groups: costs related to health services provided by
Lausanne University Hospital (intramural insurance costs) and costs related to services pro-
vided by providers other than the hospital (extramural insurance costs). Thus, the costs of
health services used within the hospital were assessed from 2 different perspectives, yielding
different outcomes, which, because of their definitions, are difficult to compare directly.
For several reasons, including patient consent, cooperation of health insurance companies,
and accuracy of information transmitted, insurance cost data were available for a subsample of
participants only (n = 140, 56%; control n = 65, 52%; treatment n = 75, 60%). These data were
available for people alive at the end of the study. Individual average total monthly insurance
costs were calculated.
2.3. Statistical analyses
The analyses were performed according to the intention-to-treat principle. Descriptive statis-
tics were computed by using means, median for continuous variables, absolute frequencies,
and percentages for categorical variables. Statistical comparisons between the control and
treatment groups were performed with the Student’s t-test for age and chi-squared tests for
categorical variables. Differences in costs across treatment and control groups were assessed
with unadjusted regressions.
Because of the skewed and heavy-tailed nature of cost data, we used alternative regression
methods that have been widely tested in the econometric literature [28–31], although no single
approach emerges as optimal [32]. Generalized linear models (GLMs) offer several advantages
in this context [33, 34]. We used gamma GLMs with a log link that performed better for
modeling the variables of costs and are commonly used with health care expenditures [35, 36].
The log link allowed us to interpret exponentiated coefficients easily as the multiplicative effect
on the outcome of a unit change in the regressor.
We also analyzed the variation in individual costs by using multivariate regressions to assess
the contribution of patient characteristics to the main cost components from the hospital per-
spective (total costs, ambulatory costs, ED costs) and from the insurance perspective (total,
intramural and extramural costs). These analyses allowed us to better identify the aspects of
the lives of frequent ED users in order to focus on the context of CM interventions. We inc-
luded, as covariates, patient group (variable took a value of 1 if the patient was in the treatment
group; 0 otherwise), gender (1 for men; 0 otherwise), Swiss citizenship (1 if the patient had
Swiss citizenship; 0 otherwise), whether the patient died during follow-up (1 if the patient died;
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0 otherwise) and age (considered as a continuous variable). In addition, 4 other binary vari-
ables capturing social difficulties, somatic conditions, mental health problems, and risky behav-
iors were included. The variable social difficulty took a value of 1 if the patient presented at
least one of the following: a complex family situation, social isolation, financial hardship, inad-
equate housing, lack of employment or other activities, problems with immigration status, or
limited French proficiency; it took a value of 0 otherwise. Somatic condition took a value 1 if
the patient presented at least one of the following: severe chronic and/or acute illness, comor-
bidity, polypharmacy, treatment nonadherence, or physical handicap; it took a value of 0 oth-
erwise. Similarly, mental health problem took a value of 1 with at least one of the following
diagnoses: depression, anxiety, or personality and psychotic disorders; it took a value of 0 oth-
erwise. Finally, presenting a risky health behavior referred to any of the following diagnoses:
alcohol abuse problem, illicit drug use, tobacco use, or game addiction. In addition, the impact
of having a primary care physician (value of 1) or not (0) was tested.
The results of unadjusted and multivariate regressions report the exponentiated coeffi-
cients, namely, the relative risks (RRs) with 95% confidence intervals (CIs) and p values for
gamma-log GLMs for each cost outcome. Statistical analyses were performed with STATA
software (version 14; StataCorp LP, College Station, TX, USA).
3. Results
Baseline characteristics of the 250 patients in the trial are presented in Table 1. There were no
differences between the treatment and control groups in terms of demographic characteristics
(gender and age), determinants of health (social difficulty, somatic and mental health problem,
and risky behavior), and having a primary care physician, given the random allocation across
treatment and control groups. Twenty patients, equally distributed between the 2 groups, died
after 5.4 months of follow-up on average (same for both groups). More information about the
patients who died during the follow-up period has been published elsewhere (see [37]).
Table 2 presents data on hospital costs for health care services provided by the hospital for
the entire sample and for the 2 treatment groups. Overall, most patients (248/250) used health
care delivered by the hospital during follow-up, yielding an average monthly cost of CHF
3,754 for the hospital. On average, somatic acute hospitalizations represented 65% of total hos-
pital costs; 60% of patients (61% in the treatment group and 58% in the control group) had at
least one acute inpatient stay. Almost all patients (97%) had at least one ambulatory visit to the
hospital, with ambulatory care amounting to CHF 718 per month on average. Although
Table 1. Demographic characteristics and determinants of health in the sample studied.
Whole sample (n = 250) Control group (n = 125) Treatment group (n = 125)
Gender
Female
Male
107 (42.8)
143 (57.2)
52 (41.6)
73 (58.4)
55 (44.0)
70 (56.0)
Age, mean (SD) 46.1 (18.9) 46.3 (19.2) 46.0 (18.6)
Swiss citizenship 119 (47.6) 61 (48.8) 58 (46.4)
Social difficulty 182 (72.8) 89 (71.2) 93 (74.4)
Somatic condition 173 (69.2) 83 (66.4) 90 (72.0)
Mental health problem 126 (50.4) 64 (51.2) 62 (49.6)
Risky behavior 70 (28.0) 32 (25.6) 38 (30.4)
Not having a primary care physician 35 (14.0) 15 (12.0) 20 (16.0)
Notes: All data are reported as number (%), except where otherwise indicated.
https://doi.org/10.1371/journal.pone.0199691.t001
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psychiatric care accounted for 11% of hospital costs on average, only 35 of 250 participants
used this type of service (21 in the control group and 14 in the treatment group) during the 12
months of follow-up.
Patients in the treatment group had lower ED (-19%), ambulatory (-10%), psychiatric (-48%),
and total (-4%) costs than did the control group, although the differences were not statistically
significant. Somatic inpatient costs for patients in the treatment group were 3% higher than
those for the control group, but the difference, again, was not statistically significant. Participants
who died during the study had on average significantly higher total costs than did patients who
were still alive at the end of the follow-up period (see Table A in S1 Text for details).
Table 3 shows the costs from the hospital perspective, as the exponentiated coefficients of
gamma-log GLMs for the 3 main cost outcomes: total, ambulatory, and ED. Regressions on
total hospital costs exhibited an RR that was lower than that for the treatment group, indicat-
ing that CM was associated with decreased costs. However, this RR was not statistically signifi-
cant (RR = 0.86, p = 0.45). All else being equal, dying during the trial was strongly associated
with higher costs (RR = 3.69, p<0.001). A higher age, Swiss citizenship, having at least one
social difficulty, and having at least one mental disorder were positively and significantly asso-
ciated with higher total costs (p<0.001, p = 0.01, p = 0.07, p = 0.06, respectively). The other var-
iables, such as gender, having a somatic condition, or having a risky behavior with respect to
drug and alcohol use did not have a significant impact on total hospital costs.
Multivariate regressions of the 2 other types of hospital costs, namely, ambulatory and ED,
also showed a statistically significant impact of social difficulty on costs. CM had no significant
effect on these costs. The other variables affected ambulatory and ED costs differently. Dying
during the follow-up period, age, and Swiss citizenship were significant predictors of higher
ED costs, whereas being male was associated with lower ED costs. Mental disorders were asso-
ciated with higher ambulatory costs, but having a risky behavior was associated with lower
ambulatory costs (p = 0.06).
Table 2. Cost data from the hospital perspective for the whole sample, the control group, and the treatment group.
Hospital
perspective
monthly
costs
Whole sample (n = 250) Control group (n = 125) Treatment group (n = 125) Percentage
of variations
in mean
costs
between
treatment
and control
groupsb
Unadjusted regressions
comparing costs of
treatment and control
groups
Median Mean Mean for
positive
costs
n
with
costs
>0a
Median Mean Mean for
positive
costs
n
with
costs
>0a
Median Mean Mean for
positive
costs
n
with
costs
>0a
Relative
risk
(RR)c
95% CI P
value
Total 1,164 3,754 3,785 248 1,178 3,838 3,869 124 1,083 3,670 3,700 124 -4 0.96 0.62–1.47 0.83
Ambulatory 330 718 742 242 377 754 779 121 290 682 704 121 -10 0.90 0.58–1.42 0.65
Somatic
inpatient
337 2,424 4,040 150 434 2,390 3,879 77 176 2,458 4,209 73 3 1.03 0.59–1.80 0.90
Rehabilitation 0 204 2,555 20 0 157 2,178 9 0 252 2,863 11 61 1.24d 0.50–3.11 0.64
Psychiatric 0 408 2,914 35 0 537 3,198 21 0 279 2,490 14 -48 0.62d 0.30–1.29 0.20
ED 164 378 457 207 232 419 508 103 153 338 406 104 -19 0.81 0.54–1.21 0.29
Notes: All costs are monthly costs and expressed in CHF.
a Number of observations with costs >0 are reported.
b Variations in mean costs between treatment and control groups expressed in percentage of variations.
c For each cost outcome, the relative risk (RR) from the unadjusted gamma-log GLMs regressions is reported.
d Because of data distribution (few individuals with costs greater than 0; see columns reporting the number of observations with costs >0), logit models were run to
identify differences between groups. This assesses differences in the probability of having costs greater than 0 rather than differences in averaged costs.
https://doi.org/10.1371/journal.pone.0199691.t002
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From a broader perspective of analyzing insurance costs related to services used within and
used outside the hospital, the descriptive statistics presented in Table 4 show that, on average,
monthly total insurance costs of frequent ED users amounted to CHF 2,150. Compared with
those in the control group, patients in the treatment group had 24% higher intramural costs, a
nonsignificant difference (p = 0.35).
To check for potential sample selection biases regarding the availability of insurance cost
data, we compared the sample characteristics between treatment and control groups of the
restricted sample (n = 140). They were similar regarding their demographic, clinical, and social
characteristics (see Table A in S2 Text), as well as their total hospital costs (Table B in S2 Text).
Multivariate regressions of insurance costs outcomes (Table 5) showed that, among fre-
quent users, age (RR = 1.02; 95% CI = 1.01–1.04) and social difficulties (RR = 1.88; 95%
CI = 1.3–2.7) were positively and significantly associated with total, intramural, and extramu-
ral insurance costs. Risky behaviors regarding alcohol or drugs did not impact insurance costs.
There was a positive and statistically significant association between mental health problems
(RR = 1.78; 95% CI = 1.16–2.75) and intramural insurance costs.
4. Discussion
This study assessed the impact on costs of a CM intervention targeting frequent users of the
ED of Lausanne University Hospital, defined as at least 5 visits in the 12 months prior to
enrollment. Despite differences in costs between patients in the intervention and the control
groups, our results do not show any significant reduction in costs associated with the interven-
tion, either for the hospital that housed the intervention or for the insurance companies cover-
ing health care costs. Despite these overall negative results, our approach adds to the literature
on CM interventions by investigating their impact on several types of costs evaluated from
both hospital and insurance perspectives.
Table 3. Results of gamma-log GLMs for cost outcomes evaluated from the hospital perspective: Total, ambulatory, and ED costs.
Total monthly hospital costs Monthly ambulatory costs Monthly ED costs
RR Std.
Err.
95% CI P value RR Std.
Err.
95% CI P value RR Std.
Err.
95% CI P value
Group (ref = CM group) 0.86 0.17 0.59–1.27 0.45 0.94 0.19 0.63–1.39 0.75 0.84 0.12 0.63–1.13 0.26
Dying during follow-up (ref. = alive at the end of
follow-up)
3.69 1.30 1.85–7.35 <0.001 1.08 0.35 0.57–2.06 0.81 2.33 0.66 1.34–4.07 <0.003
Age 1.02 0.00 1.01–1.04 <0.001 1.01 0.00 1.00–1.02 0.23 1.02 0.00 1.01–1.03 <0.001
Swiss citizenship (ref. = no Swiss citizenship) 1.73 0.37 1.13–2.64 0.01 1.31 0.26 0.89–1.93 0.18 1.81 0.30 1.31–2.51 <0.001
Male gender 0.83 0.16 0.57–1.21 0.33 0.91 0.15 0.65–1.27 0.58 0.73 0.11 0.55–0.99 0.04
Social difficulty 1.44 0.29 0.97–2.15 0.07 1.58 0.30 1.09–2.29 0.02 1.69 0.27 1.24–2.31 <0.001
Somatic condition 0.85 0.20 0.54–1.36 0.51 0.88 0.22 0.54–1.46 0.63 1.2 0.20 0.85–1.69 0.3
Mental health problem 1.45 0.28 0.99–2.11 0.06 1.47 0.27 1.03–2.11 0.03 1.12 0.16 0.83–1.51 0.45
Risky behavior 0.72 0.16 0.46–1.12 0.14 0.66 0.15 0.43–1.02 0.06 0.88 0.15 0.62–1.24 0.46
Not having primary care physician 1.09 0.31 0.61–1.93 0.78 1.23 0.38 0.67–2.28 0.51 1.04 0.25 0.65–1.68 0.86
AIC = 18 BIC = −819.049 AIC = 15.12 BIC = −938.90 AIC = 13.51 BIC = −1069.22
Observations 250 250 250
Notes: The 3 main outcomes of hospital costs were analyzed. RR: relative risk (exponentiated coefficients); Std. Err.: standard error; CI: confidence interval;
AIC: Akaike information criterion; BIC: Bayesian information criterion.
 p< 0.05.
 p< 0.01.
 p< 0.001
https://doi.org/10.1371/journal.pone.0199691.t003
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From the hospital perspective, the cost components associated with ED visits, ambulatory
care, inpatient stays, and psychiatric care did not differ between patients receiving CM and
patients receiving SC. In a similar clinical setting and from the hospital perspective as well,
Shumway et al. showed that a CM intervention led to a reduction in the number of ED visits
Table 4. Cost data from insurance perspective: Total, intramural, and extramural costs for control and treatment groups.
Insurance
monthly
costs
Total (n = 140) Control group (n = 65) Treatment group (n = 75) Percentage of
variations in
mean costs
between
treatment
and control
groupsb
Unadjusted regressions
comparing costs of
treatment and control
groups
Median Mean Mean for
positive
costs
n
with
costs
>0a
Median Mean Mean for
positive
costs
n
with
costs
>0a
Median Mean Mean for
positive
costs
n
with
costs
>0a
Relative
risk
(RR)c
95% CI P
value
Total
insurance
costs
1,297 2,147 2,147 140 1,009 2,046 2,046 65 1,628 2,235 2,235 75 9 1.09 0.75–1.60 0.64
Intramural
costs
485 1,249 1,267 138 387 1,104 1,122 64 730 1,374 1,392 74 24 1.24 0.78–1.98 0.35
Extramural
costs
527 898 898 140 519 942 942 65 546 861 861 75 -9 0.91 0.60–1.40 0.62
Notes: Costs are monthly costs and expressed in CHF. Insurance costs are associated with health services used within the hospital that housed the intervention
(intramural costs) and with those used outside the hospital (extramural costs).
a The number of observations with costs >0 are reported.
b Variations in mean costs between treatment and control groups expressed in percentage of variations.
c For each cost outcome, the relative risk (RR) from the unadjusted gamma-log GLM regressions is reported for the restricted sample of 140 individuals.
https://doi.org/10.1371/journal.pone.0199691.t004
Table 5. Results of the gamma-log GLMs for total, intramural, and extramural costs evaluated from the insurance perspective.
Total Insurance costs Intramural costs Extramural costs
RR Std. Err. 95% CI P value RR Std. Err. 95% CI P value RR Std. Err. 95% CI P value
Group
(CM group = reference)
1.10 0.19 0.78–1.55 0.58 1.22 0.26 0.80–1.86 0.36 0.92 0.17 0.64–1.33 0.67
Age 1.02 0.00 1.01–1.04 <0.001 1.02 0.00 1.01–1.04 <0.001 1.03 0.00 1.01–1.04 <0.001
Swiss citizenship
(ref = no Swiss citizenship)
1.54 0.30 1.05–2.27 0.03 1.60 0.38 1.00–2.55 0.05 1.44 0.33 0.92–2.26 0.11
Male gender 0.87 0.14 0.63–1.19 0.39 0.96 0.19 0.65–1.42 0.83 0.8 0.15 0.54–1.17 0.24
Social difficulty 1.88 0.34 1.31–2.70 <0.001 1.66 0.37 1.06–2.59 0.03 2.24 0.45 1.51–3.33 <0.001
Somatic condition 1.15 0.26 0.73–1.81 0.55 1.34 0.39 0.75–2.41 0.32 1.01 0.23 0.65–1.59 0.95
Mental health problem 1.51 0.28 1.05–2.16 0.03 1.78 0.39 1.16–2.75 0.01 1.22 0.22 0.84–1.75 0.29
Risky behavior 0.93 0.19 0.62–1.39 0.72 0.77 0.19 0.47–1.28 0.31 1.17 0.23 0.79–1.72 0.44
Not having primary care physician 1.06 0.29 0.62–1.82 0.82 1.28 0.47 0.62–2.63 0.51 0.84 0.21 0.51–1.39 0.49
AIC = 17.19 BIC = -496.20 AIC = 16.04 BIC = -408.13 AIC = 15.46 BIC = -400.20
Observations 140 140 140
Notes: Intramural costs are those associated with health services used within the hospital that housed the intervention, whereas extramural costs are those associated
with health services outside the hospital. RR: relative risk (exponentiated coefficients); Std. Err: standard error; CI: confidence interval; AIC: Akaike information
criterion; BIC: Bayesian information criterion.
 p< 0.05.
 p< 0.01.
 p< 0.001.
https://doi.org/10.1371/journal.pone.0199691.t005
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and in ED costs [13]. However, the authors did not find any reduction in the costs of other
health services provided by the hospital such as inpatient care, ambulatory care, and psychiat-
ric services for CM patients compared with those for SC patients.
From the insurance perspective, the evaluation of health care resources used by frequent ED
users underlines several important points. With monthly insurance costs of CHF 2,150, health
expenditures of frequent users are almost 5 times higher than the average monthly insurance
costs per insured resident living in the same region. In 2013, the average monthly health insur-
ance costs in the canton of Vaud were CHF 483 per inhabitant [38]. The magnitude of this differ-
ence demonstrates that this particular group may have an important impact on the health system
as a whole. This result is consistent with previous studies showing that a majority of frequent ED
users had significantly higher levels of health care use, including primary care [39–41]. In our
sample, about 86% of the patients reported having a primary care physician. Hence, it is probably
not the lack of access to primary care that leads these patients to seek emergency care. In the
United States, frequent ED users were more likely than infrequent users to have a primary care
physician [42]. Thus, this population does not necessarily use ED as a “substitute” for primary
care, but likely uses it because of more pronounced needs for health care overall [40].
Previous articles have underlined that many frequent ED users have broad and complex
medical and nonmedical needs. This vulnerable population subgroup often accumulates
somatic and psychiatric disorders [3, 43], as well as precarious social situations [44]. These fac-
tors are clearly highlighted in our study, in which 51% of individuals had mental health prob-
lems, 70% somatic conditions, and 73% social difficulties.
As discussed in the literature that seeks to differentiate between the respective influence of
age, proximity of death, and morbidity on health care costs of aging populations [45–48], our
analysis showed that the use of health care resources increases in the period close to death.
From the hospital perspective, total costs associated with frequent users who died during the
study were on average 4 times higher than those associated with patients who were still alive. In
particular, inpatient costs were 5 times higher and ED costs more than 3 times higher. Before a
patient dies, morbidity often increases, leading to more treatments and thus to an increase in
health care use and costs. Multivariate regressions, when demographic variables were controlled
for, also underlined that dying has an impact on health care costs. More generally, our multivar-
iate regressions add to the knowledge about frequent ED users by identifying which of the fre-
quent users’ characteristics drive their health care costs. Thus, beyond proximity of death, age,
and citizenship, mental disorders and social difficulties, including social isolation, housing insta-
bility, and financial insecurity, play a crucial role by driving both higher costs for the hospital
and higher health expenditures for the insurer. Overall, these results provide information on the
aspects that call for special attention in the implementation of CM interventions and the follow-
up of these patients. Thus, as was the case for the CM intervention implemented at Lausanne
University Hospital, improving the social situation of frequent ED users may be beneficial for
the individuals themselves, for the hospital ED, and for the health care system overall.
Our study highlights that, among the insurance costs in the studied population, about 40%
occurred outside the hospital that housed the intervention, underlining the importance of con-
sidering a perspective that is broader than that of the hospital. However, frequent users may
turn to the hospital for specific types of care such as those related to mental disorders, which
were found to affect intramural but not extramural costs. Indeed, 60% of health care costs on
average were induced by health care services, including a mix of inpatient and ambulatory care
for somatic and psychiatric care provided at Lausanne University Hospital, indicating a certain
preference for the hospital. The distance between the health care providers and the patient’s
residence is known to play a role in the choice of health care provider. Previous studies have
shown that most of the frequent users lived within 8 kilometers of the ED [43, 44].
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Our analysis addressed several shortcomings of the literature by analyzing health care
resources—expressed as global insurance costs—used outside the hospital that housed the
intervention. However, identifying the nature of every service—primary care and other hospi-
tal services—would have been relevant in order to check whether and to what extent frequent
users use emergency care in other hospitals. [41], who did not find that CM intervention was
successful in decreasing ED visits by frequent users (>10 ED visits in 21 months), tracked ED
use at the university hospital that housed the intervention, as well as at other community hos-
pitals in the city. Their figures showed that ED visits in other community hospitals were also
substantial and thus worth taking into account.
The study has several limitations. First, the costs of the intervention itself were impossible
to assess. Indeed, some of the physicians working as members of the CM team also delivered
care to the SC group. Thus, it was not possible to evaluate the time specifically allocated to
each of the 2 groups. From the hospital perspective, the management of these 250 frequent
users over the study period cost approximately CHF 4.3 million overall for patients in the CM
group versus CHF 5.0 million for SC patients, that is, almost CHF 700,000 less. It would have
been interesting to learn the extent to which the investment in the CM program may have
been compensated for by the reduction in treatment costs. However, our results suggest that
the intervention may have interesting economic mechanisms and affect hospital productivity.
Treatment is associated with a 14% economic reduction in total costs from the hospital per-
spective on the one hand (RR = 0.86; see Table 3) and with an economic increase in intramural
insurance costs on the other. CM is associated with an increase in hospital revenues paid by
the insurance companies and thus, the CM intervention may lead to an increase in hospital
productivity. CM intervention may also reduce ED visit costs, allowing the identification of
patients with unmet needs and their appropriate outpatient care. Further investigations are
required regarding these mechanisms and impacts because our results are not statistically sig-
nificant. A second limitation of the study concerns its power. The sample size may not be suffi-
cient to perform cost analyses and find statistical differences between groups. The protocol
established that 250 patients (125 in each group) was the sample size required to detect a bet-
ween-group average reduction in the primary outcome of the study (a reduction of 2 visits per
year to the ED) [27]. However, no calculations were made to determine the required sample
size to detect a between-group average reduction in costs. Moreover, the sample studied in the
cost analysis from the insurance perspective was reduced to a subsample (140/250), limiting
the statistical power of the analysis.
Like most studies investigating the impact of a CM intervention, the time frame of the anal-
ysis was relatively short and did not exceed several months. Given the multiple and complex
needs of these patients, time may be needed for such an intervention to take effect. A longer
follow-up period could have elicited long-term and potentially significant effects in reducing
health care use and expenditures. Frequent users may require long and intensive support to
recover from problems such as mental health disorders, addiction, and social difficulties [49].
In addition, analyzing the trends and changes in costs over a longer period could be interest-
ing. In a first step, one might expect that the intervention, by allowing identification of needs,
would lead to an increase in health care use and then its costs. In a second step, the services
offered by the intervention, by improving health status and social conditions, might induce a
reduction in health care service use and its associated costs.
5. Conclusion
In this study, we used data from an RCT to compare a CM intervention with SC among fre-
quent ED users of an urban public hospital in CH. The results show that frequent users of
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health care services inside the hospital that housed the intervention are also frequent users of
health care services outside the hospital. This specific group has above-average health care
costs, mainly driven by complex clinical (somatic and psychic) conditions and social determi-
nants. The role of the CM team is to guide patients through the care process and provide social
support. Patient-centered care is part of a continuous integration of medical and social dimen-
sions, and the location of intervention is not limited to the hospital but often extends into the
community. Further investigations with a larger sample, an increased power of analysis, and
over a longer study period are required to validate the extent to which a CM intervention may
improve the management of frequent users at the ED and reduce the economic burden that
these patients place on hospital budgets, as well as on the health care system overall.
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